Why AI Alone Won’t Solve Drug Discovery

AI mind concept art

Verseon is an AI-powered drug company – in theory, anyway. The Bay Area startup does use machine learning to help predict which combination of molecules will yield novel compound to test in the lab. With over a dozen drug candidates at different stages of development, Verseon’s approach seems to be working. So when the company’s CEO had some choice words about AI, it was a little bit surprising.

The post Why AI Alone Won’t Solve Drug Discovery appeared first on HPCwire.

More Related Posts

Project Manager

We’re seeking a Project Manager to work with the most cutting edge...

‘Conduct-A-Bot’ system uses muscle signals to control drones

Albert Einstein famously postulated that “the only real valuable thing is intuition,”...

Researchers building robot with wheels and legs to traverse any terrain

Concept of the adaptable Wheel-and-Leg Transformable Robot being developed by Texas A&M...

Home

Highly Niched Headhunters Specialized in Physical AI/Robotics, High-Performance Computing, Unmanned/Autonomous Systems, Defense Technology and Energy.

Specializations

We recruit across complex engineering markets where understanding the technology is critical to finding the right talent.

How We Work

Overview of how PACE partners with teams: Our process, what clients get, and why PACE is different.

About Us

PACE’s story, values, and culture define how we operate and who we are.

News & Insights

Stay up to date on industry trends.

Contact

All the information needed for anyone interested in contacting us.